Abu-Dhabi’s ADQ acquires Egypt-based Amoun Pharmaceutical Co. from Bausch Health Cos.
Abu Dhabi’s third investment fund, ADQ, has acquired for $740 million Egypt-based Amoun Pharmaceutical Co. controlled by Canada-based Bausch Health Companies Inc. Bausch Health Companies Inc. in a statement Wednesday said it reached a deal with ADQ to relinquish its Read more